Global Anti-CD47 Antibody Supply, Demand and Key Producers, 2024-2030

Global Anti-CD47 Antibody Supply, Demand and Key Producers, 2024-2030

The global Anti-CD47 Antibody market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

The industry trend of Anti-CD47 Antibody is highly promising and gaining significant attention in the field of cancer research and drug development. Several pharmaceutical companies and research institutions are actively pursuing the development of Anti-CD47 Antibody-based therapies. There is a growing interest in combining this antibody with other immuno-oncology agents, such as checkpoint inhibitors, to enhance its therapeutic efficacy. Clinical trials evaluating the safety and efficacy of Anti-CD47 Antibody treatments in various cancer types are ongoing and showing encouraging results. The advancement of precision medicine and personalized cancer therapies further supports the potential of Anti-CD47 Antibody as a valuable addition to the oncology treatment armamentarium.

An Anti-CD47 Antibody is a type of antibody that targets the CD47 protein, which is overexpressed in various types of cancer cells. CD47 acts as a "don't eat me" signal, preventing the immune system's macrophages from engulfing and destroying cancer cells. The Anti-CD47 Antibody works by blocking the CD47 protein, thereby allowing the immune system to recognize and eliminate cancer cells effectively. This antibody has shown promise as a potential therapeutic agent in cancer immunotherapy, as it enhances the body's natural immune response against cancer while minimizing toxic side effects.

This report studies the global Anti-CD47 Antibody demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Anti-CD47 Antibody, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Anti-CD47 Antibody that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Anti-CD47 Antibody total market, 2019-2030, (USD Million)

Global Anti-CD47 Antibody total market by region & country, CAGR, 2019-2030, (USD Million)

U.S. VS China: Anti-CD47 Antibody total market, key domestic companies and share, (USD Million)

Global Anti-CD47 Antibody revenue by player and market share 2019-2024, (USD Million)

Global Anti-CD47 Antibody total market by Type, CAGR, 2019-2030, (USD Million)

Global Anti-CD47 Antibody total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Anti-CD47 Antibody market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BosterBio, Leinco Technologies, Bioss, Novus Biologicals, Thermo Fisher Scientific, Biorbyt, Abbexa, Bio X Cell and GeneTex, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Anti-CD47 Antibody market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Anti-CD47 Antibody Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Anti-CD47 Antibody Market, Segmentation by Type
Monoclonal Antibody
Polyclonal Antibody

Global Anti-CD47 Antibody Market, Segmentation by Application
Biotechnology
Medical
University
Others

Companies Profiled:
BosterBio
Leinco Technologies
Bioss
Novus Biologicals
Thermo Fisher Scientific
Biorbyt
Abbexa
Bio X Cell
GeneTex
R&D Systems
LSBio
MyBioSource
ProSci
antibodies-online
ABclonal Technology
Abnova Corporation
G Biosciences
BioLegend
Bio-Rad
Huabio
BPS Bioscience
OriGene Technologies
St John's Laboratory
Absolute Antibody
NSJ Bioreagents
Cell Signaling Technology
RayBiotech
Beijing Solarbio Science & Technology
Bethyl Laboratories
Abeomics

Key Questions Answered

1. How big is the global Anti-CD47 Antibody market?

2. What is the demand of the global Anti-CD47 Antibody market?

3. What is the year over year growth of the global Anti-CD47 Antibody market?

4. What is the total value of the global Anti-CD47 Antibody market?

5. Who are the major players in the global Anti-CD47 Antibody market?